Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity

Sachiko Yokoo1, Atsushi Yonezawa, Satohiro Masuda

  • 1Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto 606-8507, Japan.

Insights

Cisplatin causes severe kidney damage due to higher renal accumulation, unlike other platinum drugs. This nephrotoxicity is linked to specific transporter interactions, explaining differences in platinum-based chemotherapy side effects.

Area of Science:

  • Pharmacology
  • Nephrology
  • Toxicology

Background:

  • Severe nephrotoxicity is a significant side effect of platinum-based chemotherapy agents.
  • The precise mechanisms underlying differential nephrotoxicity among platinum drugs like cisplatin, carboplatin, oxaliplatin, and nedaplatin remain unclear.

Purpose of the Study:

  • To investigate the renal accumulation and nephrotoxicity of four platinum agents in a rat model.
  • To elucidate the role of organic cation transporters (OCTs) and multidrug and toxin extrusion (MATE) transporters in platinum-induced nephrotoxicity.

Main Methods:

  • Rats were administered cisplatin, carboplatin, oxaliplatin, or nedaplatin intraperitoneally.
  • Renal accumulation and markers of kidney injury (NAG, KIM-1, osteopontin) were assessed.
  • In vitro studies using cell lines expressing rat and human OCT and MATE transporters were performed to evaluate drug transport.

Main Results:

  • Cisplatin induced significant nephrotoxicity and higher renal accumulation compared to other platinum agents.
  • Urinary NAG activity and kidney injury markers were elevated in cisplatin-treated rats.
  • In vitro, cisplatin and oxaliplatin cellular uptake was mediated by OCT2, while oxaliplatin was also transported by OCT3, MATE1, MATE2-K, but cisplatin was not transported by MATEs.

Conclusions:

  • Platinum agent nephrotoxicity is closely correlated with their renal accumulation.
  • The substrate specificity of OCT and MATE transporter families significantly influences platinum drug accumulation and subsequent nephrotoxicity.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...